New Two-Pronged attack tested for stubborn blood cancer
NCT ID NCT05927571
Summary
This early-stage study is testing the safety and best dose of a new two-drug combination (cevostamab and elranatamab) for people with multiple myeloma that has returned or stopped responding to other treatments. The main goals are to see what side effects occur and to find the right dose for future, larger studies. It will involve about 120 participants and is the first step in seeing if this combination can help control this serious blood cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center.
RECRUITINGSeoul, 05505, South Korea
-
Calvary Mater Newcastle
RECRUITINGWaratah, New South Wales, 2298, Australia
-
Hadassah University Hospital - Ein Kerem
RECRUITINGJerusalem, 9112001, Israel
-
Rambam Health Care Campus
RECRUITINGHaifa, 3109600, Israel
-
Royal Adelaide Hospital;Haematology Clinical Trials Unit
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Royal Prince Alfred Hospital
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
Samsung Medical Center - PPDS
RECRUITINGSeoul, 06351, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 03722, South Korea
-
Sheba Medical Center - PPDS
RECRUITINGRamat Gan, 5262000, Israel
-
St. Vincent's Hospital Melbourne
RECRUITINGMelbourne, Victoria, 3065, Australia
-
Tel Aviv Sourasky Medical Center PPDS
RECRUITINGTel Aviv, 6423906, Israel
-
The Alfred Hospital
RECRUITINGPrahan, Victoria, 3181, Australia
-
The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital)
RECRUITINGSeocho, 06591, South Korea
Conditions
Explore the condition pages connected to this study.